- Home
- RMBS vs KZR Comparison
RMBS vs KZR Comparison
Compare RMBS & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBS
- KZR
- Stock Information
- Founded
- RMBS 1990
- KZR 2015
- Country
- RMBS United States
- KZR United States
- Employees
- RMBS N/A
- KZR N/A
- Industry
- RMBS Semiconductors
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- RMBS Technology
- KZR Health Care
- Exchange
- RMBS Nasdaq
- KZR Nasdaq
- Market Cap
- RMBS 8.0B
- KZR 29.7M
- IPO Year
- RMBS 1997
- KZR 2018
- Fundamental
- Price
- RMBS $96.28
- KZR $6.36
- Analyst Decision
- RMBS Strong Buy
- KZR Hold
- Analyst Count
- RMBS 6
- KZR 4
- Target Price
- RMBS $97.83
- KZR $6.00
- AVG Volume (30 Days)
- RMBS 2.0M
- KZR 422.8K
- Earning Date
- RMBS 10-27-2025
- KZR 11-11-2025
- Dividend Yield
- RMBS N/A
- KZR N/A
- EPS Growth
- RMBS 0.94
- KZR N/A
- EPS
- RMBS 2.11
- KZR N/A
- Revenue
- RMBS $645,488,000.00
- KZR N/A
- Revenue This Year
- RMBS $27.27
- KZR N/A
- Revenue Next Year
- RMBS $13.97
- KZR N/A
- P/E Ratio
- RMBS $45.59
- KZR N/A
- Revenue Growth
- RMBS 35.17
- KZR N/A
- 52 Week Low
- RMBS $40.12
- KZR $3.53
- 52 Week High
- RMBS $109.15
- KZR $8.60
- Technical
- Relative Strength Index (RSI)
- RMBS 54.48
- KZR 84.60
- Support Level
- RMBS $90.00
- KZR $4.10
- Resistance Level
- RMBS $101.00
- KZR $4.45
- Average True Range (ATR)
- RMBS 4.86
- KZR 0.32
- MACD
- RMBS -1.33
- KZR 0.17
- Stochastic Oscillator
- RMBS 32.79
- KZR 98.72
About RMBS Rambus Inc.
Rambus Inc is a semiconductor solutions provider offering high-speed, high-security computer chips and Silicon intellectual property. The company's key products include memory interface chips, built for high speed and efficiency; silicon IP, providing high-speed memory and chip-to-chip connection technology; and architecture licenses, which allow customers to use portions of Rambus' patented inventions for their own digital electronics. The firm receives the majority of its revenue from the United States, Taiwan, Asia, Japan, and Singapore.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.